LYNPARZA Pancreas Cancer Japan Post-Marketing Surveillance (PMS)

Clinical trial NCT04889404 · COMPLETED

Trial details

NCT number: NCT04889404
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Pancreatic Neoplasms

Start date: 2021-05-22
Primary completion: 2025-02-06
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.